SynthesisBreast cancer (Tokyo, Japan)2020

Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials.

Minoru Miyashita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.